2023 annual financial data
Capricor Therapeutics 2023 Operating margin
Capricor Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was -95.63%.
Operating income was -24,077,859 USD and net income was -22,287,542 USD.
Operating cash flow was -25,596,545 USD.
Get free Capricor Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 25,178,066 USD
- Operating income
- -24,077,859 USD
- Net income
- -22,287,542 USD
- Operating cash flow
- -25,596,545 USD